Case Report
Published on 16 Feb 2026
Stage IIIB ROS1-Positive NSCLC management: crizotinib + surgery + TCM achieves exceptionally prolonged PFS (a case report)
in Pharmacology of Anti-Cancer Drugs
- 203 views
Case Report
Published on 16 Feb 2026
in Pharmacology of Anti-Cancer Drugs
Conceptual Analysis
Published on 16 Feb 2026
in Leadership in Education
Editorial
Published on 16 Feb 2026
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 16 Feb 2026
in Construction Materials
Original Research
Published on 16 Feb 2026
in Geohazards and Georisks
Original Research
Published on 16 Feb 2026
in Computational Genomics
Original Research
Published on 16 Feb 2026
in Digital Education
Original Research
Published on 16 Feb 2026
in Cancer Genetics and Oncogenomics
Editorial
Published on 16 Feb 2026
in Applied Genetic Epidemiology
Original Research
Accepted on 15 Feb 2026
in Diabetes Clinical Epidemiology
Case Report
Accepted on 15 Feb 2026
in Neuro-Ophthalmology Disorders
Case Report
Accepted on 15 Feb 2026
in Oral and Maxillofacial Surgery
Review
Accepted on 15 Feb 2026
in Oral Health and Nutrition
Original Research
Accepted on 15 Feb 2026
in Diabetes Cardiovascular Complications
Original Research
Accepted on 15 Feb 2026
in New Technologies in Ophthalmology
Original Research
Accepted on 14 Feb 2026
in Crop and Product Physiology
Retraction
Accepted on 14 Feb 2026
in Molecular and Cellular Oncology
Correction
Accepted on 14 Feb 2026
in Plant Abiotic Stress
Original Research
Accepted on 14 Feb 2026
in Preventive Dentistry
Original Research
Accepted on 14 Feb 2026
in Clinical Diabetes
Original Research
Accepted on 14 Feb 2026
in Neuro-Ophthalmology
Original Research
Accepted on 14 Feb 2026
in Sleep Disorders
Original Research
Accepted on 14 Feb 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 14 Feb 2026
in Veterinary Infectious Diseases